Sage Journals: Discover world-class research

Free access

Review article

First published 2014-5

Sofosbuvir,a NS5B polymerase inhibitor in the treatment of hepatitis C: a review of its clinical potential

Catherine Stedman

Therapeutic Advances in Gastroenterology

Free access

Review article

First published 2005-8

Review HCV Antiviral Resistance: The Impact of in vitro Studies on the Development of Antiviral Agents Targeting the Viral NS5B Polymerase

Licia Tomei, Sergio Altamura, Giacomo Paonessa [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Review article

First published 2014-8

Sofosbuvir

Lucia Rose, Tiffany E. Bias, Clinton B. Mathias [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2010-05

Review: New direct-acting antivirals in the development for hepatitis C virus infection

Paul J. Pockros

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2009-7

Naturally occurring substitutions conferring resistance to hepatitis C virus polymerase inhibitors in treatment-naive patients infected with genotypes 1–5

Florence Legrand-Abravanel, Cécile Henquell, Hélène Le Guillou-Guillemette [...]

Antiviral Therapy

Free access

Research article

First published 2009-8

Characterization of Aurintricarboxylic Acid as a Potent Hepatitis C Virus Replicase Inhibitor

Ye Chen, Alain Bopda-Waffo, Amartya Basu [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2019-05-18

Quantum chemical and molecular docking studies on two potential hepatitis C virus inhibitors

Gargi Tiwari, Ambrish Kumar Srivastava, Ratnesh Kumar [...]

Main Group Chemistry

Free access

Research article

First published 2017-8

The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions

Elise J Smolders, Floor AC Berden, Clara TMM de Kanter [...]

United European Gastroenterology Journal

Free access

Research article

First published 2018-1

Pooled Analysis of HCV Genotype 1 Resistance-Associated Substitutions in NS5A,NS3 and NS5B pre- and Post-Treatment with 12 Weeks of Daclatasvir,Asunaprevir and Beclabuvir

Fiona McPhee, Dennis Hernandez, Nannan Zhou [...]

Antiviral Therapy

Retricted access

Research article

First published 2003-12

Selection of DNA Aptamers That Bind the RNA-Dependent RNA Polymerase of Hepatitis C Virus and Inhibit Viral RNA Synthesis In Vitro

Pantxika Bellecave, Marie-Line Andreola, Michel Ventura [...]

Nucleic Acid Therapeutics

Search results